Literature DB >> 20143246

A pilot study of topiramate dosages for migraine prophylaxis in an Asian population.

Y L Lo1, S Y Lum, S Fook-Chong, H C Siow.   

Abstract

Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143246      PMCID: PMC3452284          DOI: 10.1007/s10194-010-0193-4

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  2 in total

1.  Efficacy of zonisamide in migraineurs with nonresponse to topiramate.

Authors:  Jin-Young Chung; Min-Wook Kim; Manho Kim
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

Review 2.  Advances in topiramate as prophylactic treatment for migraine.

Authors:  Chuan Hu; Yixin Zhang; Ge Tan
Journal:  Brain Behav       Date:  2021-09-02       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.